Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Fluzone

Fluzone

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Fluzone

22 trials tracked of Fluzone: 15 in phase 3 or 4 and 2 with published results. The most-cited published study has 51 citations.

22Trials tracked
15Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 12 Phase 3 3 Phase 2 6 Other / NA 1
  1. Phase 4 Comparison of Three Licensed Influenza Vaccines Completed · 51 cited
  2. Phase 4 Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP Completed · 45 cited
  3. Phase 4 Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4 Completed
  4. Phase 4 T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009 Completed
  5. Phase 4 Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS) Completed
  6. Phase 4 T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010 Completed
Show 16 more trials
  1. Phase 4 The Human Mucosal Immune Responses to Influenza Virus (SLVP026) Completed
  2. Phase 4 B-cell Immunity to Influenza (SLVP017)- Year 5, 2013 Completed
  3. Phase 4 Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029) Completed
  4. Phase 4 Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014) Completed
  5. Phase 4 Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals Completed
  6. Phase 4 B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011) Completed
  7. Phase 3 Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children Completed
  8. Phase 3 Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children Completed
  9. Phase 3 Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children Completed
  10. Phase 2 A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine Completed
  11. Phase 2 A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV Completed
  12. Phase 2 Influenza Vaccine in Pregnant Women Completed
  13. Phase 2 Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine Completed
  14. Phase 2 Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults Completed
  15. Phase 2 Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age Completed
  16. N/A Immune Responses Induced by Different Licensed Influenza Vaccines Completed

Showing the 22 most-cited and recently-updated of 22 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.